Cargando…
Productive common light chain libraries yield diverse panels of high affinity bispecific antibodies
The commercial success of bispecific antibodies generally has been hindered by the complexities associated with generating appropriate molecules for both research scale and large scale manufacturing purposes. Bispecific IgG (BsIgG) based on two antibodies that use an identical common light chain can...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825193/ https://www.ncbi.nlm.nih.gov/pubmed/29227213 http://dx.doi.org/10.1080/19420862.2017.1406570 |
_version_ | 1783302162837667840 |
---|---|
author | Van Blarcom, Thomas Lindquist, Kevin Melton, Zea Cheung, Wai Ling Wagstrom, Chris McDonough, Dan Valle Oseguera, Cendy Ding, Sheng Rossi, Andrea Potluri, Shobha Sundar, Purnima Pitts, Steven Sirota, Marina Galindo Casas, Meri Yan, Yu Jones, Jeffrey Roe-Zurz, Zygy Srivatsa Srinivasan, Surabhi Zhai, Wenwu Pons, Jaume Rajpal, Arvind Chaparro-Riggers, Javier |
author_facet | Van Blarcom, Thomas Lindquist, Kevin Melton, Zea Cheung, Wai Ling Wagstrom, Chris McDonough, Dan Valle Oseguera, Cendy Ding, Sheng Rossi, Andrea Potluri, Shobha Sundar, Purnima Pitts, Steven Sirota, Marina Galindo Casas, Meri Yan, Yu Jones, Jeffrey Roe-Zurz, Zygy Srivatsa Srinivasan, Surabhi Zhai, Wenwu Pons, Jaume Rajpal, Arvind Chaparro-Riggers, Javier |
author_sort | Van Blarcom, Thomas |
collection | PubMed |
description | The commercial success of bispecific antibodies generally has been hindered by the complexities associated with generating appropriate molecules for both research scale and large scale manufacturing purposes. Bispecific IgG (BsIgG) based on two antibodies that use an identical common light chain can be combined with a minimal set of Fc mutations to drive heavy chain heterodimerization in order to address these challenges. However, the facile generation of common light chain antibodies with properties similar to traditional monoclonal antibodies has not been demonstrated and they have only been used sparingly. Here, we describe the design of a synthetic human antibody library based on common light chains to generate antibodies with biochemical and biophysical properties that are indistinguishable to traditional therapeutic monoclonal antibodies. We used this library to generate diverse panels of well-behaved, high affinity antibodies toward a variety of epitopes across multiple antigens, including mouse 4-1BB, a therapeutically important T cell costimulatory receptor. Over 200 BsIgG toward 4-1BB were generated using an automated purification method we developed that enables milligram-scale production of BsIgG. This approach allowed us to identify antibodies with a wide range of agonistic activity that are being used to further investigate the therapeutic potential of antibodies targeting one or more epitopes of 4-1BB. |
format | Online Article Text |
id | pubmed-5825193 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-58251932018-03-01 Productive common light chain libraries yield diverse panels of high affinity bispecific antibodies Van Blarcom, Thomas Lindquist, Kevin Melton, Zea Cheung, Wai Ling Wagstrom, Chris McDonough, Dan Valle Oseguera, Cendy Ding, Sheng Rossi, Andrea Potluri, Shobha Sundar, Purnima Pitts, Steven Sirota, Marina Galindo Casas, Meri Yan, Yu Jones, Jeffrey Roe-Zurz, Zygy Srivatsa Srinivasan, Surabhi Zhai, Wenwu Pons, Jaume Rajpal, Arvind Chaparro-Riggers, Javier MAbs Report The commercial success of bispecific antibodies generally has been hindered by the complexities associated with generating appropriate molecules for both research scale and large scale manufacturing purposes. Bispecific IgG (BsIgG) based on two antibodies that use an identical common light chain can be combined with a minimal set of Fc mutations to drive heavy chain heterodimerization in order to address these challenges. However, the facile generation of common light chain antibodies with properties similar to traditional monoclonal antibodies has not been demonstrated and they have only been used sparingly. Here, we describe the design of a synthetic human antibody library based on common light chains to generate antibodies with biochemical and biophysical properties that are indistinguishable to traditional therapeutic monoclonal antibodies. We used this library to generate diverse panels of well-behaved, high affinity antibodies toward a variety of epitopes across multiple antigens, including mouse 4-1BB, a therapeutically important T cell costimulatory receptor. Over 200 BsIgG toward 4-1BB were generated using an automated purification method we developed that enables milligram-scale production of BsIgG. This approach allowed us to identify antibodies with a wide range of agonistic activity that are being used to further investigate the therapeutic potential of antibodies targeting one or more epitopes of 4-1BB. Taylor & Francis 2017-12-14 /pmc/articles/PMC5825193/ /pubmed/29227213 http://dx.doi.org/10.1080/19420862.2017.1406570 Text en © 2018 The Author(s). Published with license by Taylor & Francis Group, LLC http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. |
spellingShingle | Report Van Blarcom, Thomas Lindquist, Kevin Melton, Zea Cheung, Wai Ling Wagstrom, Chris McDonough, Dan Valle Oseguera, Cendy Ding, Sheng Rossi, Andrea Potluri, Shobha Sundar, Purnima Pitts, Steven Sirota, Marina Galindo Casas, Meri Yan, Yu Jones, Jeffrey Roe-Zurz, Zygy Srivatsa Srinivasan, Surabhi Zhai, Wenwu Pons, Jaume Rajpal, Arvind Chaparro-Riggers, Javier Productive common light chain libraries yield diverse panels of high affinity bispecific antibodies |
title | Productive common light chain libraries yield diverse panels of high affinity bispecific antibodies |
title_full | Productive common light chain libraries yield diverse panels of high affinity bispecific antibodies |
title_fullStr | Productive common light chain libraries yield diverse panels of high affinity bispecific antibodies |
title_full_unstemmed | Productive common light chain libraries yield diverse panels of high affinity bispecific antibodies |
title_short | Productive common light chain libraries yield diverse panels of high affinity bispecific antibodies |
title_sort | productive common light chain libraries yield diverse panels of high affinity bispecific antibodies |
topic | Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825193/ https://www.ncbi.nlm.nih.gov/pubmed/29227213 http://dx.doi.org/10.1080/19420862.2017.1406570 |
work_keys_str_mv | AT vanblarcomthomas productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies AT lindquistkevin productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies AT meltonzea productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies AT cheungwailing productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies AT wagstromchris productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies AT mcdonoughdan productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies AT valleosegueracendy productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies AT dingsheng productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies AT rossiandrea productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies AT potlurishobha productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies AT sundarpurnima productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies AT pittssteven productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies AT sirotamarina productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies AT galindocasasmeri productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies AT yanyu productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies AT jonesjeffrey productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies AT roezurzzygy productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies AT srivatsasrinivasansurabhi productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies AT zhaiwenwu productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies AT ponsjaume productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies AT rajpalarvind productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies AT chaparroriggersjavier productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies |